Roni Weissman

Roni’s focus lies in drug delivery systems and immunoengineering. During her undergraduate studies, she concentrated on SARS-CoV-2 and Influenza A Virus research. More recently, she contributed to the development of virus-like particles mimicking IAV for targeted genetic therapy delivery to challenging cells. Acknowledging her achievements, Weissman was awarded the MolE Director’s Fellowship. She holds a B.S. in bioengineering from UC Berkeley.